Head-to-head · WeighScore
CoreAge Rx vs Gala Health
The verdict
CoreAge Rx takes it — 89.5/100 to 82.9/100.
CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
CoreAge Rx scores 89.5/100 (B+).
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | CoreAge Rx | Gala Health |
|---|---|---|
| WeighScore | 89.5/100 | 82.9/100 |
| Grade | B+ | B− |
| Site position | #1 | #12 |
| Semaglutide | $99/mo | Not disclosed |
| Tirzepatide | $149/mo | $179/mo (yearly subscription) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #1 · B+
Strengths
- Advertises the same medication price at every dose
- Semaglutide and tirzepatide injection options
- No membership fee; standard prescription shipping included unless checkout states otherwise
Where it loses points
- Compounded only; no FDA-approved brand option listed
- Dispensing pharmacy not identified on the reviewed product pages
- Applicable $50–$100 consultation fee is nonrefundable after review begins
- Orders become final after approval and pharmacy transmission; 30-day refund cutoff also applies
Site position #12 · B−
Strengths
- Low compounded entry if you prepay the year — $179/mo tirzepatide and $149/mo microdose on the yearly subscription, $199/mo on a 3-month plan
- Prices are published openly rather than quiz-gated, with all doses included at the one rate
- All 50 states and LegitScript-verified, with a brand-name Ozempic path kept open ($1,299)
- HRT and menopause care available alongside GLP-1
Where it loses points
- No month-to-month price is published anywhere — the $179 tirzepatide and $149 microdose rates are both yearly subscriptions, and the shortest term Gala names is a 3-month plan at $199/mo
- Compounded formulations are not FDA-approved
- Brand-name Ozempic is priced steeply at $1,299
- No oral or sublingual route offered yet — injection only
- Newer operator (Gala GLP-1 by AI Coaching Inc) with no named clinicians and no named dispensing pharmacy
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.